marketcap
Facebook
Twitter
Telegram
Report an ErrorMillendo Therapeutics, Inc. Financial Ratios 2011-2024 | MLND
Annual Financial Ratios Millendo Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.2 | -0.0 | -0.1 | -0.0 | -0.1 | -1.3 | -0.3 | -0.2 | - |
P/S |
- | - | - | 8.8 | 5.0 | 36.8 | - | - | - | - |
EV/EBITDA |
1.0 | 1.2 | 2.7 | 0.3 | 0.6 | 0.5 | -1.2 | 0.3 | 0.9 | - |
PEG |
-0.0 | -0.0 | -0.0 | -0.0 | -0.01 | 0.01 | 0.06 | -0.02 | 0.0 | - |
P/B |
0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 1.2 | 0.2 | 0.1 | - |
P/CF |
-0.1 | -0.2 | -0.0 | -0.1 | -0.1 | -0.2 | -2.0 | -0.5 | -0.3 | - |
ROE % |
-110.13 | -76.12 | -38.33 | -79.28 | -76.01 | -57.72 | -89.51 | -69.65 | -43.98 | - |
ROA % |
-83.87 | -59.45 | -32.34 | -69.97 | -67.13 | -52.82 | -75.52 | -61.09 | -41.17 | - |
ROCE % |
-101.55 | -72.70 | -36.19 | -71.60 | -69.16 | -56.53 | -86.52 | -69.75 | -44.03 | - |
DSO |
- | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 1035.9 | 147.5 | 544.0 | - | - | - | - |
All numbers in USD currency